Products

Comprehensive catalog of pharmaceutical solutions. Browse categories and send inquiries directly.

Connect With Us

All Products (326)

Quick filters: Solid Tumour Hematologic Both Name A-Z Name Z-A

Therapeutic Areas

Sort by

Clear all filters

Molecule	Drug Class / Mechanism	Oncology Type
Binimetinib	BRAF / MEK Inhibitor	Solid Tumour
Molecule Binimetinib Therapeutic Category Targeted Therapy Oncology Type Solid Tumour Drug Class / Mechanism BRAF / MEK Inhibitor
Selumetinib	BRAF / MEK Inhibitor	Solid Tumour
Molecule Selumetinib Therapeutic Category Targeted Therapy Oncology Type Solid Tumour Drug Class / Mechanism BRAF / MEK Inhibitor
Pimasertib	BRAF / MEK Inhibitor	Solid Tumour
Molecule Pimasertib Therapeutic Category Targeted Therapy Oncology Type Solid Tumour Drug Class / Mechanism BRAF / MEK Inhibitor
Refametinib	BRAF / MEK Inhibitor	Solid Tumour
Molecule Refametinib Therapeutic Category Targeted Therapy Oncology Type Solid Tumour Drug Class / Mechanism BRAF / MEK Inhibitor
Lifirafenib	BRAF / MEK Inhibitor	Solid Tumour
Molecule Lifirafenib Therapeutic Category Targeted Therapy Oncology Type Solid Tumour Drug Class / Mechanism BRAF / MEK Inhibitor
Ulixertinib	BRAF / MEK Inhibitor	Solid Tumour
Molecule Ulixertinib Therapeutic Category Targeted Therapy Oncology Type Solid Tumour Drug Class / Mechanism BRAF / MEK Inhibitor
Naporafenib	BRAF / MEK Inhibitor	Solid Tumour
Molecule Naporafenib Therapeutic Category Targeted Therapy Oncology Type Solid Tumour Drug Class / Mechanism BRAF / MEK Inhibitor
Tovorafenib	BRAF / MEK Inhibitor	Solid Tumour
Molecule Tovorafenib Therapeutic Category Targeted Therapy Oncology Type Solid Tumour Drug Class / Mechanism BRAF / MEK Inhibitor
Palbociclib	CDK Inhibitor	Solid Tumour
Molecule Palbociclib Therapeutic Category Targeted Therapy Oncology Type Solid Tumour Drug Class / Mechanism CDK Inhibitor
Ribociclib	CDK Inhibitor	Solid Tumour
Molecule Ribociclib Therapeutic Category Targeted Therapy Oncology Type Solid Tumour Drug Class / Mechanism CDK Inhibitor
Abemaciclib	CDK Inhibitor	Solid Tumour
Molecule Abemaciclib Therapeutic Category Targeted Therapy Oncology Type Solid Tumour Drug Class / Mechanism CDK Inhibitor
Trilaciclib	CDK Inhibitor	Solid Tumour
Molecule Trilaciclib Therapeutic Category Targeted Therapy Oncology Type Solid Tumour Drug Class / Mechanism CDK Inhibitor

Binimetinib Targeted Therapy
Therapeutic Category Targeted Therapy Oncology Type Solid Tumour Drug Class / Mechanism BRAF / MEK Inhibitor
Selumetinib Targeted Therapy
Therapeutic Category Targeted Therapy Oncology Type Solid Tumour Drug Class / Mechanism BRAF / MEK Inhibitor
Pimasertib Targeted Therapy
Therapeutic Category Targeted Therapy Oncology Type Solid Tumour Drug Class / Mechanism BRAF / MEK Inhibitor
Refametinib Targeted Therapy
Therapeutic Category Targeted Therapy Oncology Type Solid Tumour Drug Class / Mechanism BRAF / MEK Inhibitor
Lifirafenib Targeted Therapy
Therapeutic Category Targeted Therapy Oncology Type Solid Tumour Drug Class / Mechanism BRAF / MEK Inhibitor
Ulixertinib Targeted Therapy
Therapeutic Category Targeted Therapy Oncology Type Solid Tumour Drug Class / Mechanism BRAF / MEK Inhibitor
Naporafenib Targeted Therapy
Therapeutic Category Targeted Therapy Oncology Type Solid Tumour Drug Class / Mechanism BRAF / MEK Inhibitor
Tovorafenib Targeted Therapy
Therapeutic Category Targeted Therapy Oncology Type Solid Tumour Drug Class / Mechanism BRAF / MEK Inhibitor
Palbociclib Targeted Therapy
Therapeutic Category Targeted Therapy Oncology Type Solid Tumour Drug Class / Mechanism CDK Inhibitor
Ribociclib Targeted Therapy
Therapeutic Category Targeted Therapy Oncology Type Solid Tumour Drug Class / Mechanism CDK Inhibitor
Abemaciclib Targeted Therapy
Therapeutic Category Targeted Therapy Oncology Type Solid Tumour Drug Class / Mechanism CDK Inhibitor
Trilaciclib Targeted Therapy
Therapeutic Category Targeted Therapy Oncology Type Solid Tumour Drug Class / Mechanism CDK Inhibitor

‹ 1 … 6 7 8 9 10 … 28 ›

Product Range

Company

Global Network

Products

Binimetinib

Selumetinib

Pimasertib

Refametinib

Lifirafenib

Ulixertinib

Naporafenib

Tovorafenib

Palbociclib

Ribociclib

Abemaciclib

Trilaciclib

Binimetinib

Selumetinib

Pimasertib

Refametinib

Lifirafenib

Ulixertinib

Naporafenib

Tovorafenib

Palbociclib

Ribociclib

Abemaciclib

Trilaciclib